Pharma Share Buybacks Could Draw Policymakers’ Scrutiny, Professor Warns
This article was originally published in The Pink Sheet Daily
Executive Summary
In current economic climate, trade-offs between buybacks and R&D investment could get a closer look, University of Massachusetts prof says at economic conference.